MoneyWorks4Me

Biocon reports 89% drop in Q3 consolidated net profit

31 Jan 2025 Evaluate

Biocon has reported results for third quarter ended December 31, 2024 (Q3FY25)

The company has reported over 24-fold jump in its net profit at Rs 584.00 crore for Q3FY25 as compared to Rs 24.00 crore for the same quarter in the previous year. Total income of the company increased by 2.57% at Rs 627.00 crore for Q3FY25 as compared to Rs 611.30 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 89.23% fall in its net profit at Rs 81.10 crore for the quarter ended December 31, 2024 as compared to Rs 753.30 crore for the same quarter in the previous year. Total income of the company decreased by 14.67% at Rs 3856.20 crore for Q3FY25 as compared to Rs 4519.20 crore for the corresponding quarter previous year.

Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1250.00
Cipla 1383.00
Lupin 2060.00
Zydus Lifesciences 1195.20
View more..